Some highly effective medications also happen to be highly mysterious. Such is the case with the antidepressant drugs known as selective serotonin reuptake inhibitors, or SSRIs: They are the most common treatment for major ...
Aug 14, 2020
0
281
Researchers at Washington University School of Medicine in St. Louis are studying the use of nitrous oxide—laughing gas—as a treatment for patients who are hospitalized due to suicidal thoughts. They are investigating ...
Nov 10, 2017
0
48
A theory that has gained considerable attention in international media, including Newsweek and the CBS broadcast 60 minutes, suggests that antidepressant drugs such as the SSRIs do not exert any actual antidepressant effect. ...
Aug 18, 2017
0
102
The difficulties that people have in discontinuing antidepressant medications has been in the news recently. An analysis published in the current issue of Psychotherapy and Psychosomatics on the effects of discontinuing commonly ...
Sep 13, 2018
0
58
The prevalence of self-reported mental health disabilities increased in the U.S. among non-elderly adults during the last decade, according to a study by Ramin Mojtabai, MD, PhD, of the Johns Hopkins Bloomberg School of Public ...
Sep 23, 2011
0
0
Winter is upon us. And with it comes the annual worsening of depressive symptoms. Sadly, in the United States, suicide continues to claim more lives than firearms, and suicide rates are increasing in nearly all states. The ...
Nov 14, 2018
0
7
When Laura Wylie became pregnant for the second time, she confronted a vexing dilemma: Stay on the antidepressants that could have adverse effects on her developing baby or risk descending into a deep, black hole that left ...
May 5, 2015
0
35
Two clinical trials of an investigational drug that targets the opioid system support its safety and effectiveness in reducing symptoms of major depression, when added to standard antidepressant treatment. The results of ...
Oct 29, 2018
0
21
In 2004, concerns about antidepressant drugs increasing suicidal thoughts and behaviors in young patients prompted the FDA to issue a rare "black box warning." Now, a new analysis of clinical trial data finds that treatment ...
Feb 6, 2012
0
0
(HealthDay) -- The Israeli drug maker Teva Pharmaceuticals has gained the first U.S. approval to market generic Lexapro (escitalopram) to treat depression and general anxiety disorder, the U.S. Food and Drug Administration ...
Mar 14, 2012
0
0
